Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2026-01-17 @ 12:47 PM
Study NCT ID:
NCT00466258
Status:
COMPLETED
Last Update Posted:
2009-11-25
First Post:
2007-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Sponsor:
PETHEMA Foundation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2006-003750-23
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Pethema
Old Organization:
pethema